Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy

被引：0

作者：

Arndt H. Brachat

Alexei A. Grom

Nico Wulffraat

Hermine I. Brunner

Pierre Quartier

Riva Brik

Liza McCann

Huri Ozdogan

Lidia Rutkowska-Sak

Rayfel Schneider

Valeria Gerloni

Liora Harel

Maria Terreri

Kristin Houghton

Rik Joos

Daniel Kingsbury

Jorge M. Lopez-Benitez

Stephan Bek

Martin Schumacher

Marie-Anne Valentin

Hermann Gram

Ken Abrams

Alberto Martini

Daniel J. Lovell

Nanguneri R. Nirmala

Nicolino Ruperto

机构：

[1] Novartis Institutes for Biomedical Research,

[2] Cincinnati Children’s Hospital Medical Center,undefined

[3] PRCSG,undefined

[4] Wilhelmina Kinderziekenhuis,undefined

[5] Department of Pediatric Immunology and Rheumatology,undefined

[6] Université Paris-Descartes,undefined

[7] IMAGINE Institute,undefined

[8] Hôpital Necker-Enfants Malades. Centre de référence national pour les Arthrites Juveniles,undefined

[9] Unité d’Immunologie,undefined

[10] Hématologie et Rhumatologie Pediatrique,undefined

[11] Rambam Medical Center,undefined

[12] Department of Pediatrics B,undefined

[13] Alder Hey Children’s NHS Foundation Trust,undefined

[14] Cerrahpasa Tip Fakultesi,undefined

[15] Ic Hastaliklari ABD,undefined

[16] Romatoloji BD,undefined

[17] Institute of Rheumatology,undefined

[18] Paediatric Clinic,undefined

[19] Hospital for Sick Children,undefined

[20] Division of Rheumatology,undefined

[21] Istituto Gaetano Pini,undefined

[22] Divisione di Reumatologia,undefined

[23] Schneider Childrens Medical Center,undefined

[24] Pediatric Rheumatology Unit,undefined

[25] Universidade Federal de São Paulo,undefined

[26] Pediatrics,undefined

[27] British Columbia Children’s Hospital,undefined

[28] Universitair Ziekenhuis Gent,undefined

[29] Centrum Voor Kinderreumatologie,undefined

[30] Randall Children’s Hospital at Legacy Emanuel,undefined

[31] Floating Hospital for Children,undefined

[32] Rheumatology NEMC 286,undefined

[33] Novartis Pharmaceuticals Corporation,undefined

[34] University of Genova and Istituto Giannina Gaslini,undefined

[35] Pediatria II-PRINTO,undefined

[36] Novartis Institutes for Biomedical Research,undefined

[37] Istituto Giannina Gaslini,undefined

[38] Pediatria II-PRINTO,undefined

来源：

Arthritis Research & Therapy | / 19卷

关键词：

Biomarkers; Canakinumab; Gene expression; Interleukin-1β; Juvenile idiopathic arthritis; SJIA;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[11] Canakinumab for the treatment of active systemic juvenile idiopathic arthritis
Orrock, Janet E.
Ilowite, Norman T.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (08) : 1015 - 1024
[12] Canakinumab treatment shows maintained efficacy in systemic juvenile idiopathic arthritis patients
NM Wulffraat
N Ruperto
HI Brunner
S Oliveira
Y Uziel
K Nistala
R Cimaz
MA Ferrandiz
B Flato
M Gamir
I Kone-Paut
C Gaillez
K Lheritier
K Abrams
A Martini
D Lovell
Pediatric Rheumatology, 12 (Suppl 1)
[13] Efficacy of Canakinumab in Systemic Juvenile Idiopathic Arthritis Patients Previously Exposed to Biologics
Brunner, Hermine I.
Ruperto, Nicolino
Quartier, Pierre
Constantin, Tamas
Berkun, Yackov
Calvo-Penedes, Inmaculada
Erguven, Mueferet
Goffin, Laurence
Hofer, Michael
Kallinich, Tilmann
Oliveira, Sheila
Uziel, Yosef
Viola, Stefania
Nistala, Kiran
Wouters, Carine
Leon, Karolynn
Speziale, Antonio
Lheritier, Karine
Junge, Guido
Lovell, Daniel
Martini, Alberto
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[14] Multiplex Serum Biomarker Analysis before and during Therapy with Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis
Hinze, Tanja
Kessel, Christoph
Hinze, Claas
Seibert, Julia
Gram, Hermann
Foell, Dirk
ARTHRITIS & RHEUMATOLOGY, 2018, 70
[15] Response to Canakinumab Treatment Is Maintained in Systemic Juvenile Idiopathic Arthritis Patients.
Wulffraat, N. M.
Ruperto, N.
Brunner, H. I.
Oliveira, S.
Uziel, Y.
Nistala, K.
Cimaz, R.
Ferrandiz, M.
Flato, B.
Gamir, M. L.
Kone-Paut, I.
Gaillez, C.
Lheritier, K.
Abrams, K.
Martini, A.
Lovell, D. J.
ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S413 - S414
[16] Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
Ruperto, Nicolino
Brunner, Hermine I.
Quartier, Pierre
Constantin, Tamas
Wulffraat, Nico
Horneff, Gerd
Brik, Riva
McCann, Liza
Kasapcopur, Ozgur
Rutkowska-Sak, Lidia
Schneider, Rayfel
Berkun, Yackov
Calvo, Inmaculada
Erguven, Muferet
Goffin, Laurence
Hofer, Michael
Kallinich, Tilmann
Oliveira, Sheila K.
Uziel, Yosef
Viola, Stefania
Nistala, Kiran
Wouters, Carine
Cimaz, Rolando
Ferrandiz, Manuel A.
Flato, Berit
Gamir, Maria Luz
Kone-Paut, Isabelle
Grom, Alexei
Magnusson, Bo
Ozen, Seza
Sztajnbok, Flavio
Lheritier, Karine
Abrams, Ken
Kim, Dennis
Martini, Alberto
Lovell, Daniel J.
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (25): : 2396 - 2406
[17] Canakinumab: A Review of Its Use in the Management of Systemic Juvenile Idiopathic Arthritis
Sheridan M. Hoy
BioDrugs, 2015, 29 : 133 - 142
[18] Canakinumab: A Review of Its Use in the Management of Systemic Juvenile Idiopathic Arthritis
Hoy, Sheridan M.
BIODRUGS, 2015, 29 (02) : 133 - 142
[19] A safety evaluation of canakinumab for the treatment of systemic onset juvenile idiopathic arthritis
Wulffraat, Nico M.
EXPERT OPINION ON DRUG SAFETY, 2015, 14 (12) : 1961 - 1967
[20] Specific gene expression profiles in systemic juvenile idiopathic arthritis
Ogilvie, Emma Mary
Khan, Arshad
Hubank, Mike
Kellam, Paul
Woo, Patricia
ARTHRITIS AND RHEUMATISM, 2007, 56 (06): : 1954 - 1965

← 1 2 3 4 5 →